Supported by favourable policies, rising domestic demand and shift towards complex active pharmaceutical ingredient (API), the Indian API market is projected to grow at a compounded annual growth rate ...
The prices for active pharmaceuticals ingredients (API) will recover in FY27 due to the implementation of minimum import price (MIP) starting from 29 January 2026 and China’s withdrawal value-added ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results